Search Results - "Meraĭ, I A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Experience of hospital initiation of sacubitril/valsartan in a female patient after acute decompensated heart failure by Galochkin, S A, Lukina, O I, Meraĭ, I A, Villevalde, S V, Kobalava, Z D

    Published in Kardiologiia (01-01-2018)
    “…The article discusses management of a female patient with chronic heart failure with reduced left ventricular ejection fraction after an episode of acute…”
    Get more information
    Journal Article
  3. 3

    Prevalence, Clinical Features, Treatment, and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries by Hoang, T H, Maiskov, V V, Merai, I A, Kobalava, Zh D

    Published in Kardiologiia (31-07-2024)
    “…To study clinical and demographic characteristics, treatment options, and clinical outcomes in patients with myocardial infarction with non-obstructive…”
    Get more information
    Journal Article
  4. 4

    Additional analysis of red blood cell distribution width improves the predictive value of the GRACE 2.0 score for 18-month mortality in patients with acute myocardial infarction by Hoang, T. H., Maiskov, V. V., Merai, I. A., Kobalava, Zh. D.

    “…Aim. To identify whether the addition of red blood cell distribution width (RDW) could improve the Global Registry of Acute Coronary Events (GRACE) risk score…”
    Get full text
    Journal Article
  5. 5

    Predictors and etiology of in-hospital mortality in patients with acute myocardial infarction by Hoang, T. H., Maiskov, V. V., Merai, I. A., Kobalava, Z. D.

    “…Aim . To identify factors and develop a clinical risk model (nomogram) for in-hospital mortality in patients with acute myocardial infarction (AMI) after…”
    Get full text
    Journal Article
  6. 6

    Prognostic Significance of Echocardiographic Characteristics in Patients with Type 2 Myocardial Infarction: comparison with Type 1 Myocardial Infarction by Hoang, T. H., Maiskov, V. V., Merai, I. A., Safarova, A. F., Kobalava, Z. D.

    “…Aim . To outline echocardiographic features and assess their prognostic significance for major cardiovascular adverse events (MACEs) within 12 months in…”
    Get full text
    Journal Article
  7. 7

    Specific features of impairment of systolic and diastolic left ventricular functions in patients with acute myocardial infarction complicated with pulmonary edema by Pavlikova, E P, Meraĭ, I A, Moiseev, V S

    Published in Kardiologiia (2006)
    “…The purpose of the study was to investigate specific features of systolic and diastolic functions of the left ventricle (LV) in patients with acute myocardial…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Organoprotective effects of serelaxin in patients with severe decompensated heart failure by Kobalava, Z. D., Villevalde, S. V., Solov'jova, A. E., Merai, I. A.

    “…Serelaxin (recombinant molecule of the human relaxin-2) is an innovative drug for the treatment of acute heart failure. Preclinical and clinical studies…”
    Get full text
    Journal Article
  10. 10

    Prognostic value of elevated transaminase levels as predictors of adverse outcomes in patients with acute myocardial infarction by Hoang, T. H., Maiskov, V. V., Merai, I. A., Kobalava, Zh. D.

    Published in Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny (11-10-2024)
    “…Aim. To assess the prevalence of elevated serum liver transaminases (LTs), including alanine aminotransferase (ALT) and aspartate aminotransferase (ALT), and…”
    Get full text
    Journal Article
  11. 11

    Application of Charlson Comorbidity Index to assess prognosis of 18-month mortality in patients with acute myocardial infarction by Hoang, T. H., Maiskov, V. V., Merai, I. A., Kobalava, Zh. D.

    Published in Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny (10-07-2024)
    “…Aim . To evaluate the prognostic value of the Charlson Comorbidity Index (CCI) for predicting 18-month all-cause mortality and develop a nomogram for…”
    Get full text
    Journal Article
  12. 12